SlideShare a Scribd company logo
1 of 26
By:Dr.M.Usman Khalid
DPT,MS-NMPT
*
*
*
*These drugs lower blood pressure by reduction
of blood volume and probably also by a direct
vascular effect.
*The diuretics most important for treating
hypertension are the thiazides (eg,
chlorthalidone, hydrochlorothiazide) and the
loop diuretics (eg, furosemide).
*
*
*
*Sympathoplegic drugs interfere with
sympathetic (SANS) control of cardiovascular
function.
*The result is a reduction of one or more of the
following: venous tone, heart rate, contractile
force of the heart, cardiac output, and total
peripheral resistance.
*
*A few natural products, such as veratrum
alkaloids, appear to increase sensitivity of
baroreceptor sensory nerves and reduce SANS
outflow while increasing vagal tone to the
heart.
*These agents are toxic and no clinically
available drugs act at this site.
*
*Alpha2-selective agonists (eg, clonidine, methyldopa)
cause decrease in sympathetic outflow by activation of
α2 receptors in the CNS.
*These drugs readily enter the CNS when given orally.
* Methyldopa is a prodrug; it is transported into the
brain and then converted to methylnorepinephrine.
*Clonidine and methyldopa reduce blood pressure by
reducing cardiac output, vascular resistance, or both.
*The major compensatory response is salt retention.
Sudden discontinuation of clonidine causes rebound
hypertension, which may be severe.
*
*Nicotinic blockers that act in the ganglia are
very efficacious, but because their adverse
effects are severe, they are now considered
obsolete.
*
*Drugs that deplete the adrenergic nerve terminal of
its norepinephrine stores (eg, reserpine) or that
deplete and block release of the stores (eg,
guanethidine, guanadrel) can lower blood
pressure.
*The major compensatory response is salt and water
retention.
*In high dosages, these drugs are very efficacious but
produce severe adverse effects and are now
considered obsolete for hypertension.
*
*Alpha1-selective agents (eg, prazosin,
doxazosin, terazosin) are moderately
effective antihypertensive drugs. Alpha
blockers reduce vascular resistance and venous
return.
*The nonselective α blockers (phentolamine,
phenoxybenzamine) are of no value in chronic
hypertension because of excessive tachycardia.
*Beta blockers are used very heavily in the
treatment of hypertension.
*Propranolol is the prototype, and atenolol,
metoprolol, and carvedilol are among the
most popular.
*They initially reduce cardiac output, but in
chronic use their action may include a
decrease in vascular resistance as a
contributing effect.
*
*Drugs that dilate blood vessels by acting
directly on smooth muscle cells through
nonautonomic mechanisms are useful in
treating some hypertensive patients.
*Vasodilators act by four major mechanisms:
blockade of calcium channels, release of nitric
oxide, opening of potassium channels (which
leads to hyperpolarization), and activation of
D1 dopamine receptors.
*
*
*Calcium channel blockers (eg, nifedipine,
verapamil, diltiazem) are effective
vasodilators.
* Because they are moderately efficacious and
orally active, these drugs are suitable for
chronic use in hypertension of any severity.
Verapamil and diltiazem also reduce cardiac
output in most patients.
*
*These older vasodilators have more effect on
arterioles than on veins.
*They are orally active and suitable for chronic
therapy.
*Hydralazine apparently acts through the release of
nitric oxide from endothelial cells.
*It causes significant baroreceptor homeostatic
responses and must be combined with other drugs,
usually diuretics and β blockers.
* However, it is rarely used at high dosage because of
its toxicity.
*
*These parenteral vasodilators are used in
hypertensive emergencies.
*Nitroprusside is a light-sensitive, short-acting
agent that must be infused continuously.
*The release of nitric oxide (from the drug
molecule itself) stimulates guanylyl cyclase
and increases cyclic guanine monophosphate
(cGMP) concentration and relaxation in
vascular smooth muscle.
*Dopamine D1 receptor activation by
fenoldopam causes prompt, marked arteriolar
vasodilation.
*This drug is given by intravenous infusion. It
has a short duration of action (10 min) and,
like nitroprusside and diazoxide, is used for
hypertensive emergencies.
*
*The two primary groups of angiotensin antagonists
are the angiotensin-converting enzyme (ACE)
inhibitors and the angiotensin II receptor blockers
(ARBs).
*ACE inhibitors (eg, captopril), which inhibit the
enzyme variously known as angiotensin- converting
enzyme, kininase II, and peptidyl dipeptidase, cause
a reduction in blood levels of angiotensin II and
aldosterone and an increase in endogenous
vasodilators of the kinin family.
*The ACE inhibitors are useful in heart failure
and diabetes as well as in hypertension.
*The toxicities of ACE inhibitors include cough,
hyperkalemia, and renal damage in occasional
patients with preexisting renal vascular
disease.
*They cause major renal damage in the fetus
and are absolutely contraindicated in
pregnancy.
*The second group of angiotensin antagonists,
the receptor blockers, is represented by the
orally active agents losartan, valsartan,
irbesartan, candesartan, and other ARBs, which
competitively inhibit angiotensin II at its AT1
receptor site.
*ARBs appear to be as effective in lowering
blood pressure as the ACE inhibitors and have
the advantage of a lower incidence of cough,
although they do cause hyperkalemia.
*
*A. Stepped Care (Polypharmacy)
*Drugs are added to a patient’s regimen in stepwise
fashion; each additional agent is chosen from a
different subgroup until adequate blood pressure
control has been achieved.
*The usual steps include (1) lifestyle measures such
as salt restriction and weight reduction, (2)
diuretics (a thiazide), (3) sympathoplegics (a β
blocker), (4) ACE inhibitors, and (5) vasodilators.
*The vasodilator chosen first is usually a calcium
channel blocker.
*B. Monotherapy
*It has been found in large clinical studies that many
patients do well on a single drug (eg, an ACE
inhibitor, calcium channel blocker, or combined α
and β blocker).
*This approach to the treatment of mild and
moderate hypertension has become more popular
than stepped care because of its simplicity, better
patient compliance, and—with modern drugs—a
relatively low incidence of toxicity.
*
*Hypertensive emergency (formerly called malignant
hypertension) is an accelerated form of severe
hypertension associated with rising blood pressure and
rapidly progressing damage to vessels and end organs.
*Management of hypertensive emergency must be
carried out on an urgent basis in the hospital.
*Powerful vasodilators (nitroprusside, fenoldopam, or
diazoxide) are combined with diuretics (furosemide)
and β blockers to lower blood pressure to the 140–
160/90–110 mm Hg range promptly (within a few
hours).
* Further reduction is then pursued more slowly.
*

More Related Content

What's hot

Antihypertensives
AntihypertensivesAntihypertensives
Antihypertensives
raj kumar
 

What's hot (20)

Antianginal drugs and drugs used in ischaemia - drdhriti
Antianginal drugs and drugs used in ischaemia - drdhritiAntianginal drugs and drugs used in ischaemia - drdhriti
Antianginal drugs and drugs used in ischaemia - drdhriti
 
Anti-hypertensive drugs
Anti-hypertensive drugs Anti-hypertensive drugs
Anti-hypertensive drugs
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 
Antihypertensive drugs
Antihypertensive drugs  Antihypertensive drugs
Antihypertensive drugs
 
ORAL HYPOGLYCEMIC AGENTS
ORAL HYPOGLYCEMIC AGENTS ORAL HYPOGLYCEMIC AGENTS
ORAL HYPOGLYCEMIC AGENTS
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Antihypertension drugs
Antihypertension drugsAntihypertension drugs
Antihypertension drugs
 
Class drug therapy of shock
Class drug therapy of shockClass drug therapy of shock
Class drug therapy of shock
 
Antiplatelet drugs
Antiplatelet drugsAntiplatelet drugs
Antiplatelet drugs
 
Pharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugsPharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugs
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 
Antiplatelet Drugs
Antiplatelet DrugsAntiplatelet Drugs
Antiplatelet Drugs
 
Pharmacology of Antiarrhythmic drugs
Pharmacology of Antiarrhythmic drugsPharmacology of Antiarrhythmic drugs
Pharmacology of Antiarrhythmic drugs
 
Calcium channel blockers nikku
Calcium channel blockers nikkuCalcium channel blockers nikku
Calcium channel blockers nikku
 
EICOSANOIDS
EICOSANOIDSEICOSANOIDS
EICOSANOIDS
 
Drugs for diabetes - Pharmacology
Drugs for diabetes - PharmacologyDrugs for diabetes - Pharmacology
Drugs for diabetes - Pharmacology
 
Antihypertensives
AntihypertensivesAntihypertensives
Antihypertensives
 
Antihypertensive agents
Antihypertensive agentsAntihypertensive agents
Antihypertensive agents
 
ACE Inhibitors
ACE InhibitorsACE Inhibitors
ACE Inhibitors
 
Drugs used in cardio vascular system- Mr. panneh
Drugs used in cardio vascular system- Mr. pannehDrugs used in cardio vascular system- Mr. panneh
Drugs used in cardio vascular system- Mr. panneh
 

Similar to Drugs Used in Hypertension

vasodilator final ppt.pptx
vasodilator final ppt.pptxvasodilator final ppt.pptx
vasodilator final ppt.pptx
Dhruv Saini
 
Anti Hypertensive Drugs
Anti Hypertensive DrugsAnti Hypertensive Drugs
Anti Hypertensive Drugs
Shams Patel
 
Antihypertensive drugs and diuretics.pptx
Antihypertensive drugs and diuretics.pptxAntihypertensive drugs and diuretics.pptx
Antihypertensive drugs and diuretics.pptx
AnthonyMatu1
 

Similar to Drugs Used in Hypertension (20)

Hypertension II
Hypertension IIHypertension II
Hypertension II
 
Anti hypertension drugs and treatment
Anti hypertension drugs and treatmentAnti hypertension drugs and treatment
Anti hypertension drugs and treatment
 
Hypertension treatment strategies: By RxVichuZ!!
Hypertension treatment strategies: By RxVichuZ!!Hypertension treatment strategies: By RxVichuZ!!
Hypertension treatment strategies: By RxVichuZ!!
 
Cardiovascular drugs..pptx
Cardiovascular drugs..pptxCardiovascular drugs..pptx
Cardiovascular drugs..pptx
 
Anti-Hypertensive drugs
Anti-Hypertensive drugsAnti-Hypertensive drugs
Anti-Hypertensive drugs
 
hypertension.pptx
hypertension.pptxhypertension.pptx
hypertension.pptx
 
Anti Hypertensive.pptx
Anti Hypertensive.pptxAnti Hypertensive.pptx
Anti Hypertensive.pptx
 
Pharma seminar new version
Pharma seminar new versionPharma seminar new version
Pharma seminar new version
 
Antihypertensive drugs 2015-16
Antihypertensive drugs 2015-16Antihypertensive drugs 2015-16
Antihypertensive drugs 2015-16
 
Antihypertensives | Classes of Drugs | Baro Receptor
Antihypertensives | Classes of Drugs | Baro ReceptorAntihypertensives | Classes of Drugs | Baro Receptor
Antihypertensives | Classes of Drugs | Baro Receptor
 
vasodilator final ppt.pptx
vasodilator final ppt.pptxvasodilator final ppt.pptx
vasodilator final ppt.pptx
 
Anti Hypertensive Drugs
Anti Hypertensive DrugsAnti Hypertensive Drugs
Anti Hypertensive Drugs
 
Antihypertensive drugs and diuretics.pptx
Antihypertensive drugs and diuretics.pptxAntihypertensive drugs and diuretics.pptx
Antihypertensive drugs and diuretics.pptx
 
Ant ihypertensive
Ant ihypertensiveAnt ihypertensive
Ant ihypertensive
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Drugs used in hypertension
Drugs used in hypertensionDrugs used in hypertension
Drugs used in hypertension
 
Antihypertensive.pptx
Antihypertensive.pptxAntihypertensive.pptx
Antihypertensive.pptx
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
drugs used in high BP-anti-hypertensive drugs.pptx
drugs used in high BP-anti-hypertensive drugs.pptxdrugs used in high BP-anti-hypertensive drugs.pptx
drugs used in high BP-anti-hypertensive drugs.pptx
 
Antihypertensives Ch 1.pptx
Antihypertensives Ch 1.pptxAntihypertensives Ch 1.pptx
Antihypertensives Ch 1.pptx
 

More from UsmanKhalid135

More from UsmanKhalid135 (20)

Sympathomimetics
SympathomimeticsSympathomimetics
Sympathomimetics
 
Introduction to autonomic pharmacology
Introduction to autonomic pharmacologyIntroduction to autonomic pharmacology
Introduction to autonomic pharmacology
 
Cholinoceptor activating and cholinesterase-inhibiting drugs
Cholinoceptor activating and cholinesterase-inhibiting drugsCholinoceptor activating and cholinesterase-inhibiting drugs
Cholinoceptor activating and cholinesterase-inhibiting drugs
 
Cholinoceptor Blockers
Cholinoceptor BlockersCholinoceptor Blockers
Cholinoceptor Blockers
 
Adrenergic Receptor Blockers
Adrenergic Receptor BlockersAdrenergic Receptor Blockers
Adrenergic Receptor Blockers
 
Pharmacokinetics Drug Distribution
Pharmacokinetics Drug DistributionPharmacokinetics Drug Distribution
Pharmacokinetics Drug Distribution
 
Pharmacokinetics Drug Transportation
Pharmacokinetics  Drug TransportationPharmacokinetics  Drug Transportation
Pharmacokinetics Drug Transportation
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Introduction to Pharmacology
Introduction to PharmacologyIntroduction to Pharmacology
Introduction to Pharmacology
 
Drug Elimination
Drug EliminationDrug Elimination
Drug Elimination
 
Bioavailability
BioavailabilityBioavailability
Bioavailability
 
Opioid Analgesics
Opioid AnalgesicsOpioid Analgesics
Opioid Analgesics
 
Drugs in Parkinsonism
Drugs in ParkinsonismDrugs in Parkinsonism
Drugs in Parkinsonism
 
Anti Pscychotic Drugs
Anti Pscychotic DrugsAnti Pscychotic Drugs
Anti Pscychotic Drugs
 
Anti Depressive Drugs
Anti Depressive DrugsAnti Depressive Drugs
Anti Depressive Drugs
 
Drugs used in Heart Failure
Drugs used in Heart FailureDrugs used in Heart Failure
Drugs used in Heart Failure
 
Drugs Used In Angina
Drugs Used In AnginaDrugs Used In Angina
Drugs Used In Angina
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 
Nsaids, Acetaminophen
Nsaids, AcetaminophenNsaids, Acetaminophen
Nsaids, Acetaminophen
 
Coagulation Disorders
Coagulation DisordersCoagulation Disorders
Coagulation Disorders
 

Recently uploaded

Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
ssuserdda66b
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Recently uploaded (20)

Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 

Drugs Used in Hypertension

  • 2. *
  • 3. * *These drugs lower blood pressure by reduction of blood volume and probably also by a direct vascular effect. *The diuretics most important for treating hypertension are the thiazides (eg, chlorthalidone, hydrochlorothiazide) and the loop diuretics (eg, furosemide).
  • 4. *
  • 5. *
  • 6. * *Sympathoplegic drugs interfere with sympathetic (SANS) control of cardiovascular function. *The result is a reduction of one or more of the following: venous tone, heart rate, contractile force of the heart, cardiac output, and total peripheral resistance.
  • 7. * *A few natural products, such as veratrum alkaloids, appear to increase sensitivity of baroreceptor sensory nerves and reduce SANS outflow while increasing vagal tone to the heart. *These agents are toxic and no clinically available drugs act at this site.
  • 8. * *Alpha2-selective agonists (eg, clonidine, methyldopa) cause decrease in sympathetic outflow by activation of α2 receptors in the CNS. *These drugs readily enter the CNS when given orally. * Methyldopa is a prodrug; it is transported into the brain and then converted to methylnorepinephrine. *Clonidine and methyldopa reduce blood pressure by reducing cardiac output, vascular resistance, or both. *The major compensatory response is salt retention. Sudden discontinuation of clonidine causes rebound hypertension, which may be severe.
  • 9. * *Nicotinic blockers that act in the ganglia are very efficacious, but because their adverse effects are severe, they are now considered obsolete.
  • 10. * *Drugs that deplete the adrenergic nerve terminal of its norepinephrine stores (eg, reserpine) or that deplete and block release of the stores (eg, guanethidine, guanadrel) can lower blood pressure. *The major compensatory response is salt and water retention. *In high dosages, these drugs are very efficacious but produce severe adverse effects and are now considered obsolete for hypertension.
  • 11. * *Alpha1-selective agents (eg, prazosin, doxazosin, terazosin) are moderately effective antihypertensive drugs. Alpha blockers reduce vascular resistance and venous return. *The nonselective α blockers (phentolamine, phenoxybenzamine) are of no value in chronic hypertension because of excessive tachycardia.
  • 12. *Beta blockers are used very heavily in the treatment of hypertension. *Propranolol is the prototype, and atenolol, metoprolol, and carvedilol are among the most popular. *They initially reduce cardiac output, but in chronic use their action may include a decrease in vascular resistance as a contributing effect.
  • 13. * *Drugs that dilate blood vessels by acting directly on smooth muscle cells through nonautonomic mechanisms are useful in treating some hypertensive patients. *Vasodilators act by four major mechanisms: blockade of calcium channels, release of nitric oxide, opening of potassium channels (which leads to hyperpolarization), and activation of D1 dopamine receptors.
  • 14. *
  • 15. * *Calcium channel blockers (eg, nifedipine, verapamil, diltiazem) are effective vasodilators. * Because they are moderately efficacious and orally active, these drugs are suitable for chronic use in hypertension of any severity. Verapamil and diltiazem also reduce cardiac output in most patients.
  • 16. * *These older vasodilators have more effect on arterioles than on veins. *They are orally active and suitable for chronic therapy. *Hydralazine apparently acts through the release of nitric oxide from endothelial cells. *It causes significant baroreceptor homeostatic responses and must be combined with other drugs, usually diuretics and β blockers. * However, it is rarely used at high dosage because of its toxicity.
  • 17. * *These parenteral vasodilators are used in hypertensive emergencies. *Nitroprusside is a light-sensitive, short-acting agent that must be infused continuously. *The release of nitric oxide (from the drug molecule itself) stimulates guanylyl cyclase and increases cyclic guanine monophosphate (cGMP) concentration and relaxation in vascular smooth muscle.
  • 18. *Dopamine D1 receptor activation by fenoldopam causes prompt, marked arteriolar vasodilation. *This drug is given by intravenous infusion. It has a short duration of action (10 min) and, like nitroprusside and diazoxide, is used for hypertensive emergencies.
  • 19. * *The two primary groups of angiotensin antagonists are the angiotensin-converting enzyme (ACE) inhibitors and the angiotensin II receptor blockers (ARBs). *ACE inhibitors (eg, captopril), which inhibit the enzyme variously known as angiotensin- converting enzyme, kininase II, and peptidyl dipeptidase, cause a reduction in blood levels of angiotensin II and aldosterone and an increase in endogenous vasodilators of the kinin family.
  • 20. *The ACE inhibitors are useful in heart failure and diabetes as well as in hypertension. *The toxicities of ACE inhibitors include cough, hyperkalemia, and renal damage in occasional patients with preexisting renal vascular disease. *They cause major renal damage in the fetus and are absolutely contraindicated in pregnancy.
  • 21. *The second group of angiotensin antagonists, the receptor blockers, is represented by the orally active agents losartan, valsartan, irbesartan, candesartan, and other ARBs, which competitively inhibit angiotensin II at its AT1 receptor site. *ARBs appear to be as effective in lowering blood pressure as the ACE inhibitors and have the advantage of a lower incidence of cough, although they do cause hyperkalemia.
  • 22.
  • 23. * *A. Stepped Care (Polypharmacy) *Drugs are added to a patient’s regimen in stepwise fashion; each additional agent is chosen from a different subgroup until adequate blood pressure control has been achieved. *The usual steps include (1) lifestyle measures such as salt restriction and weight reduction, (2) diuretics (a thiazide), (3) sympathoplegics (a β blocker), (4) ACE inhibitors, and (5) vasodilators. *The vasodilator chosen first is usually a calcium channel blocker.
  • 24. *B. Monotherapy *It has been found in large clinical studies that many patients do well on a single drug (eg, an ACE inhibitor, calcium channel blocker, or combined α and β blocker). *This approach to the treatment of mild and moderate hypertension has become more popular than stepped care because of its simplicity, better patient compliance, and—with modern drugs—a relatively low incidence of toxicity.
  • 25. * *Hypertensive emergency (formerly called malignant hypertension) is an accelerated form of severe hypertension associated with rising blood pressure and rapidly progressing damage to vessels and end organs. *Management of hypertensive emergency must be carried out on an urgent basis in the hospital. *Powerful vasodilators (nitroprusside, fenoldopam, or diazoxide) are combined with diuretics (furosemide) and β blockers to lower blood pressure to the 140– 160/90–110 mm Hg range promptly (within a few hours). * Further reduction is then pursued more slowly.
  • 26. *